Risk assessment of osteoradionecrosis associated with periodontitis using

Fluorodeoxyglucose F18 Head and Neck Neoplasms Humans Neoplasm Recurrence, Local Osteoradionecrosis / diagnostic imaging Periodontitis / diagnostic imaging Positron Emission Tomography Computed Tomography Radiopharmaceuticals Retrospective Studies Risk Assessment
Osteoradionecrosis Periodontitis Positron emission tomography computed tomography Radiotherapy Squamous cell carcinoma

Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 03 05 2020
revised: 28 06 2020
accepted: 26 08 2020
pubmed: 6 10 2020
medline: 15 4 2021
entrez: 5 10 2020
Statut: ppublish

Résumé

Osteoradionecrosis (ORN) is a serious complication after radiotherapy (RT), even in the era of intensity modulated radiation therapy (IMRT). The purpose of this study was to evaluate whether One hundred and five OP/OC SCC patients treated with RT who underwent pretreatment Among 105 patients, 14 (13.3 %) developed ORN. The SUVmax of the periodontal region in patients with ORN (3.35 ± 1.23) was significantly higher than patients without ORN (1.92 ± 0.66) (P <  .01). The corresponding CT stage of periodontitis in patients with ORN was significantly higher (2.71±0.47) than patients without ORN (1.80±0.73) (P <  .01). ROC analysis revealed the cut-off values of developing ORN were 2.1 in SUVmax, and II in CT stage of periodontitis. The corresponding AUC was 0.86 and 0.82, respectively. Pretreatment

Identifiants

DOI: 10.1016/j.ejrad.2020.109259 PMID: 33012550
pubmed: 33012550
pii: S0720-048X(20)30448-4
doi: 10.1016/j.ejrad.2020.109259
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109259

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Kotaro Ito (K)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Radiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan.

Koji Takumi (K)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Kagoshima, Japan.

Sara K Meibom (SK)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.

Muhammad Mustafa Qureshi (MM)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.

Noriyuki Fujima (N)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.

V Carlota Andreu-Arasa (VC)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.

Minh Tam Truong (MT)

Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.

Andrew R Salama (AR)

Departments of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Oral & Maxillofacial Surgery, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA, USA.

Takashi Kaneda (T)

Department of Radiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan.

Osamu Sakai (O)

Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA; Departments of Otolaryngology - Head and Neck Surgery, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA. Electronic address: osamu.sakai@bmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Glucides › Désoses › Désoxyglucose › Fluorodésoxyglucose F18 › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Récidive tumorale locale › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Phénomènes physiques › Rayonnement › Ostéoradionécrose › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Maladies du système stomatognathique › Maladies de la bouche › Maladies parodontales › Parodontite › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Risk assessment of osteoradionecrosis...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Risk assessment of osteoradionecrosis...